Doctorado en Ciencias Biomédicas (DCB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
Grupo de Inmunología Molecular, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
Int J Mol Sci. 2024 Jul 15;25(14):7726. doi: 10.3390/ijms25147726.
Despite advances in understanding systemic lupus erythematosus (SLE), many challenges remain in unraveling the precise mechanisms behind the disease's development and progression. Recent evidence has questioned the role of programmed cell death protein 1 (PD-1) in suppressing autoreactive CD4 T cells during autoimmune responses. Research has investigated the potential impacts of PD-1 on various CD4 T-cell subpopulations, including T follicular helper (Tfh) cells, circulating Tfh (cTfh) cells, and T peripheral helper (Tph) cells, all of which exhibit substantial PD-1 expression and are closely related to several autoimmune disorders, including SLE. This review highlights the complex role of PD-1 in autoimmunity and emphasizes the imperative for further research to elucidate its functions during autoreactive T-cell responses. Additionally, we address the potential of PD-1 and its ligands as possible therapeutic targets in SLE.
尽管人们对系统性红斑狼疮(SLE)有了更深入的了解,但在揭示疾病发展和进展的确切机制方面仍面临许多挑战。最近的证据质疑程序性细胞死亡蛋白 1(PD-1)在自身免疫反应中抑制自身反应性 CD4 T 细胞的作用。研究已经探讨了 PD-1 对各种 CD4 T 细胞亚群的潜在影响,包括滤泡辅助性 T 细胞(Tfh)、循环滤泡辅助性 T 细胞(cTfh)和外周辅助性 T 细胞(Tph),这些细胞均表现出大量的 PD-1 表达,并且与多种自身免疫性疾病密切相关,包括 SLE。这篇综述强调了 PD-1 在自身免疫中的复杂作用,并强调需要进一步研究以阐明其在自身反应性 T 细胞反应中的功能。此外,我们还探讨了 PD-1 及其配体作为 SLE 潜在治疗靶点的可能性。